AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 74 filers reported holding AIMMUNE THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 6.67 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $3,000 | -100.0% | 100 | -75.0% | 0.00% | -50.0% |
| Q2 2017 | $8,000,000 | -33.3% | 400 | -33.3% | 0.00% | -33.3% |
| Q1 2017 | $12,000,000 | 0.0% | 600 | 0.0% | 0.00% | +50.0% |
| Q4 2016 | $12,000,000 | +149900.0% | 600 | +20.0% | 0.00% | +100.0% |
| Q3 2016 | $8,000 | +300.0% | 500 | +150.0% | 0.00% | 0.0% |
| Q2 2016 | $2,000 | -77.8% | 200 | -60.0% | 0.00% | -66.7% |
| Q4 2015 | $9,000 | -25.0% | 500 | 0.0% | 0.00% | -25.0% |
| Q3 2015 | $12,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|